ATE294868T1 - Impfstoff gegen streptokokkeninfektionen der gruppe a - Google Patents

Impfstoff gegen streptokokkeninfektionen der gruppe a

Info

Publication number
ATE294868T1
ATE294868T1 AT95932518T AT95932518T ATE294868T1 AT E294868 T1 ATE294868 T1 AT E294868T1 AT 95932518 T AT95932518 T AT 95932518T AT 95932518 T AT95932518 T AT 95932518T AT E294868 T1 ATE294868 T1 AT E294868T1
Authority
AT
Austria
Prior art keywords
group
fragment
vaccine against
compositions
streptococcal infection
Prior art date
Application number
AT95932518T
Other languages
English (en)
Inventor
James A Musser
Vivek Kapur
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Application granted granted Critical
Publication of ATE294868T1 publication Critical patent/ATE294868T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
AT95932518T 1994-09-14 1995-09-13 Impfstoff gegen streptokokkeninfektionen der gruppe a ATE294868T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30654294A 1994-09-14 1994-09-14
PCT/US1995/011723 WO1996008569A2 (en) 1994-09-14 1995-09-13 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof

Publications (1)

Publication Number Publication Date
ATE294868T1 true ATE294868T1 (de) 2005-05-15

Family

ID=23185762

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95932518T ATE294868T1 (de) 1994-09-14 1995-09-13 Impfstoff gegen streptokokkeninfektionen der gruppe a

Country Status (9)

Country Link
US (1) US6030835A (de)
EP (1) EP0781340B1 (de)
JP (2) JPH10505752A (de)
AT (1) ATE294868T1 (de)
AU (1) AU714435B2 (de)
CA (1) CA2199867A1 (de)
DE (1) DE69534186T2 (de)
ES (1) ES2242191T3 (de)
WO (1) WO1996008569A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601901D0 (sv) * 1996-05-20 1996-05-20 Lars Bjoerck Quinine antagonists for use as a pharmaceutical
US6242210B1 (en) 1997-05-20 2001-06-05 Actinova Limited Treatment of bacterial infections
US7087235B2 (en) * 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
WO2000067037A2 (en) * 1999-04-29 2000-11-09 Dade Microscan Inc. A combined rapid anti-microbial susceptibility assay and microorganism identification system
ATE439372T1 (de) * 2000-10-27 2009-08-15 Novartis Vaccines & Diagnostic Nukleinsäuren und proteine von gruppen a und b- streptokokken
US8337861B2 (en) * 2003-01-09 2012-12-25 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
WO2005055812A2 (en) * 2003-12-05 2005-06-23 Ciphergen Biosystems, Inc. Serum biomarkers for chagas disease
US9115382B2 (en) * 2004-06-03 2015-08-25 Leroy E. Mosher Kit for detection of hemolytic Streptococcus
US7316910B2 (en) * 2004-06-03 2008-01-08 Kinase Scientific, Llc Rapid test for hemolytic streptococcus
BR112013006951A2 (pt) * 2010-09-23 2017-05-23 Eci Biotech Inc detecção ultrassensível de streptococcus beta hemolítico
US20140294930A1 (en) 2011-08-04 2014-10-02 The Regents Of The University Of California STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
US10098940B2 (en) 2014-06-20 2018-10-16 University Of Saskatchewan Exotoxin/thermolysin compositions and methods and uses for treating or preventing laminitis
US11376588B2 (en) 2020-06-10 2022-07-05 Checkable Medical Incorporated In vitro diagnostic device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454121A (en) * 1982-07-27 1984-06-12 The University Of Tennessee Research Corporation Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes
ZA883975B (en) * 1987-06-05 1989-04-26 Commw Scient Ind Res Org Treatment and diagnosis of footrot using the basic protease of b.nodosus
FR2685334B1 (fr) * 1991-12-23 1995-05-05 Bio Merieux Polypeptides contenant des sequences caracteristiques de pyrrolidone carboxylyl peptidases, polynucleotides contenant une sequence codant pour de tels polypeptides, et leur utilisation.
DE4240056A1 (de) * 1992-11-28 1994-06-01 Boehringer Mannheim Gmbh Streptolysin O Peptidantigene und Verfahren zur Bestimmung von Streptolysin-Antikörper

Also Published As

Publication number Publication date
JP3920271B2 (ja) 2007-05-30
EP0781340B1 (de) 2005-05-04
JP2004187688A (ja) 2004-07-08
US6030835A (en) 2000-02-29
WO1996008569A3 (en) 1996-07-18
JPH10505752A (ja) 1998-06-09
EP0781340A1 (de) 1997-07-02
ES2242191T3 (es) 2005-11-01
AU714435B2 (en) 2000-01-06
AU3553895A (en) 1996-03-29
DE69534186T2 (de) 2006-03-09
DE69534186D1 (de) 2005-06-09
CA2199867A1 (en) 1996-03-21
WO1996008569A2 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
DE69534186D1 (de) Impfstoff gegen Streptokokkeninfektionen der Gruppe A
ATE442866T1 (de) Fusionsproteine aus mycobakterium tuberculosis
HUP0102304A1 (hu) B Csoportba tartozó Streptococcus antigének
MX9204685A (es) Secuencia de adn que codifica una proteina superficial externa (ospa) o derivado de la misma composicion de vacuna qe comprende tal proteina.
UA27788C2 (uk) Композиція, що містить виділений фактор лелістада, вакцинна композиція для вакцинації тварин (варіанти), діагностичний набір для виявлення антитіла
DK1347055T3 (da) Forbindelser til immunbehandling og diagnose af tuberkulose
HUP9901112A2 (hu) Szintetikus HIV-gének
HUP0203056A1 (hu) Vakcinakészítmény
MXPA03009294A (es) Proteinas de superficie de streptococcus pyogenes.
ATE240351T1 (de) Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)
DE69635783D1 (de) Antigen omp26 aus haemophilus influenzae
TR200000115T2 (tr) Tüberkülozun immünoterapi ve teşhisi için bileşikler ve bu bileşiklerin kullanımı için yöntemler.
WO2003070187A3 (en) Fusion proteins of mycobacterium tuberculosis
WO2006078318A3 (en) Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
DE69515340D1 (de) Impfstoff gegen mycobakterielle infektionen
HUP0104825A2 (hu) Gének, fehérjék és alkalmazásuk
FR2771751B1 (fr) Erythrovirus et ses applications
DK1334196T3 (da) Genomisk fragment af Streptococcus suis og kliniske anvendelser deraf
BR0208786A (pt) Métodod para identificação de proteìnas de bactérias intracelulares
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
DK1077999T3 (da) Moraxella catarrhalis-proteiner
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
Ellison et al. Serologic measures in the prevention of periodontal disease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0781340

Country of ref document: EP

REN Ceased due to non-payment of the annual fee